Overall, both groups had similar elevations of IL-2, IL-6, IL-15, IFN-γ, tumor necrosis factor- (TNF-) α, and angiopoietin (Ang-2/Ang-1) ratio following axi-cel therapy and preceding any therapeutic interventions for ICANS or CRS. The gene discussed is IL6; the disease is congenital rubella syndrome.